Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet and Vitamin D for Secondary Hyperparathyroidism
NCT02338934Phase 4Unknown
- Sponsor
- Hospital Pulau Pinang
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Hospital Pulau Pinang. Primary endpoint: Percentage reduction of iPTH levels from baseline at 6 months. Status: unknown.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT02338934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338934.